Canaan general partners Julie Grant (L) and Nina Kjellson

Canaan rais­es an­oth­er $800M as it launch­es its next fund with an em­pha­sis on biotech

Long­time VC play­er Canaan Part­ners has an­nounced its newest fund and ex­pects to fun­nel a good por­tion of that mon­ey in­to biotech over the next few years.

The tech­nol­o­gy and life sci­ences firm said it’s brought in a fresh $800 mil­lion to fund ear­ly-stage in­vest­ing. This is Canaan’s 12th such fund and ties the amount it brought in back in June 2017, which it said at the time was a com­pa­ny record.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.